Data / Form D filings / TrialSpark, Inc.
TrialSpark, Inc.: Form D filing
TrialSpark, Inc., a pharmaceuticals company in New York, NY, filed a Form D with the SEC in 2024. The latest, on July 2, 2024, reports $372.2 million sold of a $512 million offering to 16 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 16 E 34TH ST, FL 10, New York, NY, 10016
- Phone
- (866) 283-7544
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2028122
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 2, 2024 | New notice | $512,000,000 | $372,249,945 | $139,750,055 | 16 | May 21, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Alfred Lin | Director | |
| Linhao Zhang | Executive Officer, Director | |
| Michael Moritz | Director | |
| Scott Kupor | Director | |
| Benjamine Liu | Executive Officer, Director |
Other pharmaceuticals companies in New York that filed recently
- Pierrepont Therapeutics, Inc. $2.4 million · Sep 22, 2026
Every Form D from the week of Jul 1, 2024 · All recent filings in New York · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what TrialSpark, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.